The next generation sequencing market is expanding rapidly as genomic technologies move from academic research into clinical diagnostics, precision medicine, oncology, drug discovery, and personalized healthcare. Falling sequencing costs, improvements in sequencing accuracy, and growing access to advanced bioinformatics are making NGS more accessible to research institutions and healthcare organizations. The increasing prevalence of cancer and genetic disorders is also encouraging the use of genomic profiling to identify disease-related mutations and support targeted treatment decisions. At the same time, advancements in whole genome sequencing, whole exome sequencing, targeted sequencing, long-read technologies, and cloud-based data analysis are creating new opportunities. AI-powered genomic interpretation is becoming another important trend as laboratories and researchers seek faster ways to process and interpret large sequencing datasets.

Key Market Statistics

The global next generation sequencing market was valued at USD 11.3 billion in 2025 and is projected to reach USD 13.3 billion in 2026. The market is expected to reach USD 42.3 billion by 2033, expanding at a CAGR of 18.0% from 2026 to 2033. North America dominated the global market with a 44.8% revenue share in 2025, while Asia Pacific is expected to register the fastest growth during the forecast period. The U.S. held the largest country-level market share in 2025.

Consumables represented the largest product segment in 2025 and are expected to maintain strong growth because sequencing workflows require recurring purchases of sample preparation kits, target enrichment kits, reagents, and other consumable products. By technology, targeted sequencing and resequencing accounted for the largest share at 48.3% in 2025. Oncology was the leading application with a 32.0% share, while sequencing accounted for 64.3% of workflow revenue. Academic research represented the largest end-use segment at 36.0%.

Download a free sample copy of the Next Generation Sequencing market report to understand detailed coverage and inclusions in the final report

Market Drivers & Risks

One of the major factors driving NGS adoption is the increasing use of genomic information in precision medicine. Healthcare providers and pharmaceutical companies are using sequencing to identify genetic variations, understand disease mechanisms, develop targeted therapies, and support companion diagnostics. Growing cancer incidence is particularly important because genomic profiling can help identify mutations associated with tumor development and treatment response.

The declining cost of sequencing is another important driver. Improvements in sequencing chemistry, automation, platform performance, and data analysis are making advanced genomic testing more accessible. Pharmaceutical and biotechnology companies are also increasing investments in genomic research for drug discovery and development.

However, the industry faces challenges related to high initial equipment costs, complex data management, skilled workforce requirements, and the need for reliable interpretation of genomic information. Data privacy and cybersecurity are also important concerns as genomic datasets contain highly sensitive biological information. Laboratories must maintain strong quality standards and secure infrastructure while managing rapidly increasing data volumes.

Market Breakdown and Core Segments

• By product, consumables led the market in 2025. Their recurring use across research, clinical testing, pharmaceutical development, and diagnostic workflows supports consistent demand. NGS platforms are also expected to grow as sequencing chemistry, automation, and bioinformatics technologies continue to improve.
• By technology, targeted sequencing and resequencing held the largest share at 48.3% in 2025. Targeted approaches allow researchers and clinicians to focus on specific genes or genomic regions, which can simplify analysis and improve efficiency for particular clinical applications. Whole exome sequencing is expected to register the fastest growth, supported by increasing adoption in clinical diagnostics, precision medicine, and translational research.
• By application, oncology accounted for 32.0% of market revenue in 2025. NGS is increasingly being used for cancer biomarker discovery, tumor profiling, mutation identification, and research into tumor heterogeneity. Clinical research is expected to record strong growth as genomic technologies become more closely integrated with drug development and precision healthcare.
• By workflow, sequencing held the largest share at 64.3% in 2025. Data analysis is also becoming increasingly important because the growing volume of sequencing information requires advanced computational tools for variant identification, interpretation, and visualization. Grand View Research estimates that the global NGS data analysis segment will reach USD 2.07 billion by 2033.

Looking for more specific insights? Customize this report to suite your business needs

Leading Industry Players

Major companies operating in the next generation sequencing industry include:

• Illumina
• F. Hoffmann-La Roche Ltd.
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• PacBio
• Oxford Nanopore Technologies
• Revvity, Inc.
• Merck KGaA
• BGI

These companies are focusing on new sequencing platforms, advanced consumables, long-read technologies, bioinformatics, clinical applications, and strategic collaborations. Recent product developments are increasingly focused on improving sequencing speed, accuracy, workflow automation, and genomic data analysis.

Latest Related Report Explores :

• Next-generation Sequencing Services Market (2026 - 2033)
• Clinical Oncology Next Generation Sequencing Market (2025 - 2033)
• Next-generation Sequencing Library Preparation Market (2026 - 2033)
• Next-generation Sequencing Data Analysis Market (2025 - 2030)

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.